Skip to main content

Advertisement

Table 1 Characteristics of the patients and baseline coagulation parameters

From: Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study

Characteristics of the patients TEG group (N = 21) aPTT group (N = 21) P value*
Age (years) 43 (36–53) 48 (40–58) 0.24
Female sex, N (%) 13 (62) 5 (24) 0.03
BMI (kg/m2) 21.8 (20.8–26.1) 27.7 (21.2–29.4) 0.11
ECMO duration (days) 9 (7–16) 11 (4–17) 0.74
Cause of respiratory failure    0.73
 ARDS, N (%) 14 (66.7) 16 (76.2)  
 Bridge to lung transplant, N (%) 6 (28.6) 5 (23.8)  
 Status asthmaticus, N (%) 1 (4.8) 0  
Renal replacement therapy, N (%) 4 (19) 7 (33) 0.48
SOFA 7 (5–10) 9 (6–11) 0.54
ICU mortality, N (%) 4 (19) 6 (29) 0.72
Hospital mortality, N (%) 4 (19) 6 (29) 0.72
Baseline coagulation parameters    
 Platelet count (*109/L) 185 (81–205) 154 (109–268) 0.77
 Hemoglobin (g/L) 10.6 (9–11.1) 11.2 (9.8–12.3) 0.09
 Creatinine (mg/dL) 0.9 (0.4–1.0) 1.1 (08.1.62) 0.20
 Fibrinogen (mg/dL) 520 (350–626) 476 (357–573) 0.77
 PT (ratio) 1.3 (1.2–1.4) 1.3 (1.1–1.5) 0.87
 DIC°, N (%) 1 (4.8) 1 (4.8) 0.76
 DIC score° 1 (1–3) 3 (2–3) 0.33
  1. Data are reported as median (25th–75th percentile) or as absolute and relative frequencies as appropriate
  2. BMI body mass index, ARDS acute respiratory distress syndrome, SOFA sepsis-related organ failure assessment, PT prothrombin time, DIC disseminated intravascular coagulation, ICU intensive care unit
  3. *From Wilcoxon rank-sum (continuous variables) or Fisher’s exact (categorical variables) test
  4. °ISTH criteria (Taylor, FB et al. Thromb Haemost. 2001). DIC patients: #4 (aPTT group) and #30 (TEG group)